Literature DB >> 14300173

STUDIES ON GASTRIC MUCUS IN HEALTH AND DISEASE. II. EVIDENCE FOR A CORRELATION BETWEEN ABO BLOOD GROUP SPECIFICITY, ABH(O) SECRETOR STATUS, AND THE FUCOSE CONTENT OF THE GLYCOPROTEINS ELABORATED BY THE GASTRIC MUCOSA.

L C HOSKINS, N ZAMCHECK.   

Abstract

Entities:  

Keywords:  ABO FACTORS; CHEMISTRY; FUCOSE; GASTRIC JUICE; GASTRIC MUCIN; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; GLYCOPROTEINS; HEMAGGLUTINATION INHIBITION TESTS; HEXOSAMINES; HEXOSES; HISTAMINE; NITROGEN; PEPTIC ULCER; PHARMACOLOGY

Mesh：

Substances：

Year:  1965        PMID： 14300173

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

1.  Viscosity of gastric mucus in duodenal ulceration.

Authors:  J R Curt; R Pringle
Journal:  Gut       Date:  1969-11       Impact factor: 23.059

2.  [Statistical relationships beteen the abo blood groups and diseases withthe exception of infectius diseases].

Authors:  F Vogel; J Krügr
Journal:  Blut       Date:  1968-03

3.  Multiplicative effect of hyperpepsinogenemia I and non-secretor status on the risk of duodenal ulcer in siblings.

Authors:  K Sumii; A Inbe; N Uemura; M Kimura; K Haruma; M Yoshihara; H Teshima; K Inoue; H Matsubara; G Kajiyama
Journal:  Gastroenterol Jpn       Date:  1990-04

4.  Glycosyltransferases in human blood. II. Study of serum galactosyltransferase and N-acetylgalactosaminyltransferase in patients with liver diseases.

Authors:  Y S Kim; J Perdomo; J S Whitehead; K J Curtis
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

5.  A morphologic study of the behavior of biogenic amines in experimental acetic acid gastric ulcer.

Authors:  Y Teraki; M Miyasaka; T Muraki; M Sugiyama; K Yamanaka
Journal:  Gastroenterol Jpn       Date:  1982-12

6.  Glycoprotein biosynthesis in small intestine. 3. Enzymatic basis for the difference in the antigenicity of mucins.

Authors:  Y S Kim; J Perdomo
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.